ClinicalTrialsFinder

HER2-positive Early-stage Breast Cancer Clinical Trials in Newark, New Jersey

1 recruitingNewark, New Jersey

Showing 1–1 of 1 trials

Recruiting
Phase 2

Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer

HER2-positive Early-stage Breast Cancer
Rutgers, The State University of New Jersey50 enrolled7 locationsNCT07402473